10.1007/s00428-021-03104-7 - Is there a correlation between HER2 g...

This document has been corrected

Is there a correlation between HER2 gene amplification level and response to neoadjuvant treatment with trastuzumab and chemotherapy in HER2-positive breast cancer?

10.1007/s00428-021-03104-7

Published Online: 2021-05-01

Journal: Virchows Archiv•Publisher: Springer Science and Business Media LLC

Authors: Aurea Molina•Cristina Reboredo•Eva Pérez•Joaquín Mosquera•Lourdes Calvo•Lucía García-Caballero•Mari Paz Santiago•Rosalía Gallego•Silvia Antolín•Tomás García-Caballero•Ángel Concha•Ángel Vázquez-Boquete

This document has been corrected

Is there a correlation between HER2 gene amplification level and response to neoadjuvant treatment with trastuzumab and chemotherapy in HER2-positive breast cancer?

10.1007/s00428-021-03104-7

Published Online: 2021-05-01

Journal: Virchows Archiv

NOW

2021-06-12•Correction

Correction to: Is there a correlation between HER2 gene amplification level and response to neoadjuvant treatment with trastuzumab and chemotherapy in HER2‑positive breast cancer?

10.1007/s00428-021-03121-6

* information provided by CrossRef

2021-06-12•Correction

10.1007/s00428-021-03121-6

* information provided by CrossRef

2021-05-01•Published

2021-06-12•Correction

Correction to: Is there a correlation between HER2 gene amplification level and response to neoadjuvant treatment with trastuzumab and chemotherapy in HER2‑positive breast cancer?

10.1007/s00428-021-03121-6

* information provided by CrossRef

This document has been corrected

Is there a correlation between HER2 gene amplification level and response to neoadjuvant treatment with trastuzumab and chemotherapy in HER2-positive breast cancer?

10.1007/s00428-021-03104-7

Published Online: 2021-05-01

Journal: Virchows Archiv•Publisher: Springer Science and Business Media LLC